PE20020575A1 - Alquinilamidas y aplicaciones terapeuticas de la mismas - Google Patents

Alquinilamidas y aplicaciones terapeuticas de la mismas

Info

Publication number
PE20020575A1
PE20020575A1 PE2001001082A PE2001001082A PE20020575A1 PE 20020575 A1 PE20020575 A1 PE 20020575A1 PE 2001001082 A PE2001001082 A PE 2001001082A PE 2001001082 A PE2001001082 A PE 2001001082A PE 20020575 A1 PE20020575 A1 PE 20020575A1
Authority
PE
Peru
Prior art keywords
alkyl
alkynylamides
same
hexinamide
propyl
Prior art date
Application number
PE2001001082A
Other languages
English (en)
Spanish (es)
Inventor
Youssef L Bennani
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20020575A1 publication Critical patent/PE20020575A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PE2001001082A 2000-11-01 2001-10-31 Alquinilamidas y aplicaciones terapeuticas de la mismas PE20020575A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70377100A 2000-11-01 2000-11-01

Publications (1)

Publication Number Publication Date
PE20020575A1 true PE20020575A1 (es) 2002-06-25

Family

ID=24826711

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001082A PE20020575A1 (es) 2000-11-01 2001-10-31 Alquinilamidas y aplicaciones terapeuticas de la mismas

Country Status (8)

Country Link
EP (1) EP1330429A2 (fr)
JP (1) JP4115835B2 (fr)
AU (1) AU2002228726A1 (fr)
CA (1) CA2427560C (fr)
MX (1) MXPA03003926A (fr)
PE (1) PE20020575A1 (fr)
UY (1) UY26997A1 (fr)
WO (1) WO2002036546A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050101655A1 (en) * 2003-11-12 2005-05-12 Artman Linda D. Migraine treatments including isovaleramide compounds and serotonin agonists
DE102005062987A1 (de) * 2005-12-28 2007-07-05 Grünenthal GmbH Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585358A (en) * 1993-07-06 1996-12-17 Yissum Research Development Corporation Of The Hebrew University Of Jerusalem Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents

Also Published As

Publication number Publication date
CA2427560C (fr) 2010-12-07
AU2002228726A1 (en) 2002-05-15
JP2004532804A (ja) 2004-10-28
MXPA03003926A (es) 2004-05-24
JP4115835B2 (ja) 2008-07-09
EP1330429A2 (fr) 2003-07-30
UY26997A1 (es) 2002-07-31
WO2002036546A3 (fr) 2002-10-10
CA2427560A1 (fr) 2002-05-10
WO2002036546A2 (fr) 2002-05-10

Similar Documents

Publication Publication Date Title
PE20020504A1 (es) N-acilsulfonamidas promotoras de apoptosis
PE20020753A1 (es) Heteroaromaticos fusionados como activadores de la glucoquinasa
AR027406A1 (es) Moduladores de receptores canabinoides, sus procesos de preparacion y uso de los moduladores de receptores canabinoides para el tratamiento de enfermedadesrespiratorias y no respiratorias.
PE20020335A1 (es) Acetamida de benceno de alfa-acil- y alfa-heteroatomo-sustituido como activadores de la glucoquinasa
PE20020220A1 (es) Compuestos de nitrilo de dipeptido como inhibidores de catepsina k
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
PE20040574A1 (es) Agonistas de los receptores cannabinoides
CO5601012A2 (es) Compuestos que modulan la actividad de ppar
CY1108703T1 (el) Αλλοστερικοι ρυθμιστες μεταβολοτροπων υποδοχεων γλουταμικου
EA200201046A1 (ru) 7- или 9-замещенные соединения тетрациклина, способ их получения (варианты), фармацевтическая композиция, способ лечения состояния, чувствительного к действию тетрациклина, у млекопитающего и реакционноспособное промежуточное производное
ES2183331T3 (es) Inhibidores de sulfamida-metaloproteasa.
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
CO5601013A2 (es) Compuestos que modulan la actividad de ppar
PE20050012A1 (es) Compuestos de benzopirano como inhibidores de la ciclooxigenasa-2
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
PE20020191A1 (es) Pirrolidinas 1,3-disustituidas y 1,3,3-trisustituidas como ligandos del receptor de histamina y sus aplicaciones terapeuticas
PE14696A1 (es) Derivado de fenetanolamina
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
PE20050160A1 (es) 3-aminopirrolidinas como inhibidores de la captacion de monoaminas
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
PE20020575A1 (es) Alquinilamidas y aplicaciones terapeuticas de la mismas
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
BRPI0416678A (pt) pirazolpirimidinas
PE20030613A1 (es) Compuestos de 1h-quinolin-2-ona sustituidos
ATE196464T1 (de) Benzol-derivate, verwendbar für ischämische erkrankungen

Legal Events

Date Code Title Description
FA Abandonment or withdrawal